• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridopyrimidines Pyrido[2,3-d]pyrimidines

Comprehensive Guide to Pyrido[2,3-d]pyrimidine,4,6-dichloro- (CAS No. 746671-61-4): Properties, Applications, and Market Insights

Pyrido[2,3-d]pyrimidine,4,6-dichloro- (CAS No. 746671-61-4) is a heterocyclic organic compound that has garnered significant attention in pharmaceutical and agrochemical research. This dichlorinated pyridopyrimidine derivative is known for its versatile applications in drug discovery and material science. With the increasing demand for novel bioactive molecules, this compound has become a focal point for researchers exploring kinase inhibitors and anticancer agents.

The molecular structure of 4,6-dichloropyrido[2,3-d]pyrimidine features a fused bicyclic system with two chlorine atoms at positions 4 and 6. This unique arrangement contributes to its electron-deficient character, making it an excellent scaffold for nucleophilic substitution reactions. Recent studies highlight its potential as a building block for small molecule therapeutics, particularly in the development of targeted cancer therapies and antiviral compounds.

In pharmaceutical applications, Pyrido[2,3-d]pyrimidine,4,6-dichloro- serves as a key intermediate for synthesizing tyrosine kinase inhibitors. These inhibitors play a crucial role in treating various cancers by blocking specific signaling pathways. Researchers are particularly interested in its potential to create next-generation EGFR inhibitors, addressing the growing need for drug-resistant cancer treatments.

The agrochemical industry has also recognized the value of 4,6-dichloro-pyridopyrimidine derivatives. These compounds show promise as plant growth regulators and pesticide intermediates, aligning with the global trend toward sustainable agriculture. With increasing concerns about food security and crop protection, this compound's role in developing environmentally friendly agrochemicals is gaining prominence.

From a synthetic chemistry perspective, Pyrido[2,3-d]pyrimidine,4,6-dichloro- offers excellent reactivity for cross-coupling reactions and metal-catalyzed transformations. Its versatility makes it valuable for combinatorial chemistry approaches, enabling rapid generation of diverse compound libraries for high-throughput screening in drug discovery programs.

The global market for pyridopyrimidine derivatives is experiencing steady growth, driven by increasing R&D investments in precision medicine and personalized therapeutics. As pharmaceutical companies seek to expand their pipelines with novel small molecule drugs, demand for high-quality intermediates like 4,6-dichloropyrido[2,3-d]pyrimidine continues to rise. Market analysts project particularly strong growth in the oncology drug development segment.

Quality control and analytical characterization of Pyrido[2,3-d]pyrimidine,4,6-dichloro- are critical for research applications. Advanced techniques such as HPLC purity analysis, mass spectrometry, and NMR spectroscopy are routinely employed to ensure compound integrity. The pharmaceutical industry's emphasis on quality by design (QbD) principles has further elevated the importance of rigorous chemical characterization protocols.

Recent innovations in green chemistry have explored more sustainable synthetic routes to dichloropyridopyrimidine derivatives. Researchers are developing catalyst-free reactions and microwave-assisted synthesis methods to reduce environmental impact while maintaining high yields. These advancements align with the chemical industry's shift toward green synthetic methodologies and process intensification.

For researchers working with Pyrido[2,3-d]pyrimidine,4,6-dichloro-, proper storage conditions and handling procedures are essential to maintain stability. The compound typically requires protection from moisture and should be stored in airtight containers under inert atmosphere. These precautions ensure the material remains suitable for sensitive medicinal chemistry applications.

The future outlook for 4,6-dichloropyrido[2,3-d]pyrimidine appears promising, with ongoing research exploring its potential in protein degradation technologies like PROTACs (Proteolysis Targeting Chimeras). As the field of targeted protein degradation gains momentum, this compound's unique properties may open new avenues for undruggable target intervention. Additionally, its applications in material science, particularly in the development of organic electronic materials, represent an emerging area of interest.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)